SZSE Ticker: 300529

Jafron Biomedical Co., Ltd.

健帆生物科技集团股份有限公司

健帆生物

JAFRON

Listing Date: 2016-08-02

Board: GEM

Industry Classification: Manufacturing

Jianfan Bio (300529.SZ): Chief Financial Officer He Xiaolian completed the reduction of 18,200 shares_Stock Information_Market Gold Online

Post date May 11, 2022 — 21:08 Post Lock

National Health Commission: my country has not found any cases of acute hepatitis of unknown cause in children

Post date May 7, 2022 — 22:24 Post Lock

National Health Commission: my country has not found any cases related to acute hepatitis in children of unknown cause, and is closely monitoring and continuously monitoring the relevant situation_Shenzhen Hotline

Post date May 7, 2022 — 21:36 Post Lock

The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in 6 days and 5 boards.

Post date May 7, 2022 — 14:11 Post Lock

The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in 6 days and 5 boards.

Post date May 7, 2022 — 13:06 Post Lock

The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in 6 days and 5 boards.

Post date May 7, 2022 — 09:29 Post Lock

The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in six days and five boards.

Post date May 7, 2022 — 07:56 Post Lock

The etiology of hepatitis in children is complicated and confusing. Another country announced 8 cases in 5 days. Hepatitis concept stocks hit a record high in 6 days and 5 boards.

Post date May 7, 2022 — 07:55 Post Lock

The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry

Post date May 6, 2022 — 18:35 Post Lock

Summary of the 2021 annual report and 2022 first quarter report of the medical sector of Sinolink Securities: The overall performance is clear, and it still maintains a strong growth ability! -Funds Financial Sector

Post date May 5, 2022 — 16:30 Post Lock

The boom is still high! The 2021 annual report of CSI Medical ended perfectly, and the performance of the top ten stocks increased by 48%! 1st Quarterly Report Gao Liang Continues-Funds-Finance

Post date April 29, 2022 — 18:55 Post Lock

The boom is still high! The 2021 annual report of CSI Medical ended perfectly, and the performance of the top ten stocks increased by 48%! The first quarterly report Gao Liang continues-

Post date April 29, 2022 — 16:55 Post Lock

The performance is still high! The 2021 annual report profits of 44 CSI Medical shares increased by 32%! 1st Quarterly Report Gao Liang Continues-Funds-Finance

Post date April 28, 2022 — 11:27 Post Lock

The domestic liver drug market is expected to reach 100 billion, and the performance of 15 concept stocks is expected to continue to grow rapidly Finance and Economics

Post date April 27, 2022 — 02:37 Post Lock

Live Preview 2022 M&A Prospects of the Medical Device Industry

Post date April 26, 2022 — 23:43 Post Lock

Live Preview 2022 M&A Prospects of the Medical Device Industry

Post date April 26, 2022 — 00:26 Post Lock

Unexplained hepatitis broke out in many countries, concept stocks with high performance growth were released, and funds from the north increased their positions in two stocks – yqqlm

Post date April 25, 2022 — 19:46 Post Lock

Aiming at "carbon neutrality", the first batch of ETFs tracking SEEE carbon neutrality is reported by listed companies_Shenzhen Hotline

Post date April 25, 2022 — 02:02 Post Lock

Halo no longer? ! Hou Hao's management scale fell below 100 billion, and Liu Gesong's star products fell below 10 billion! Fund managers actively responded to the adjustment of positions, and Wang Zong’s collection concentrated on buying silver – yqqlm

Post date April 24, 2022 — 17:27 Post Lock

Hou Hao's management scale fell below 100 billion, and Liu Gesong's star products fell below 10 billion! Fund managers adjust their positions actively, and Wang Zong gathers to buy bank stocks – yqqlm

Post date April 24, 2022 — 13:16 Post Lock

Want to see more data? Registered subscribers can see all the data.